We are searching a new colleague for CCP histology lab

13. 05. 2022 Information Jobs

A new position of a Histology Lab Technician is available in the CCP. For more details go to our Career page.

Вакансії для біженців з України

18. 03. 2022 Information Jobs

Czech Centre for Phenogenomics пропонує науковцям та лаборантам з України можливість займатися дослідницькою діяльністю в нашому центрі. Ми також вітаємо тих, хто зацікавлений у посаді лаборанта з догляду за лабораторними тваринами для якої не потрібно мати наукову освіту. Для отримання більш детальної інформації, будь ласка, відвідайте сторінку вакансій на нашому веб-сайті.

Towards precision medicine and gene therapy – a new AV21 Strategy programme

01. 03. 2022 Information News PR

Czech Centre for Phenogenomics is coordinating a new research programme “Towards precision medicine and gene therapy” of the AV21 Strategy. Our programme benefits from the synergistic expertise of all partners and creates a multidisciplinary consortium covering the areas of gene editing, organic chemistry of nucleic acid delivery systems, preclinical models of human diseases, and starting with neurosciences…

Mice and genetic scissors help Czech scientists seek treatment for “angelic” children

28. 02. 2022 Information News

On the occasion of the International Day of Rare Diseases Czech Centre for Phenogenomics in collaboration with BIOCEV and Czech Academy of Sciences issued a press release summarizing their research in the area of rare diseases. The press release (in English) is available on the BIOCEV website. The press release (in Czech) is available on…

Mouse models from the Czech Centre for Phenogenomics help in researching Angelman’s syndrome

14. 02. 2022 Information News

We are celebrating the International Angelman Day on 15th February. Angelman’s syndrome is an inherited disease of the central nervous system that causes severe physical and mental disabilities. The team of the Czech Center for Phenogenomics is engaged in research of Angelman’s syndrome (and other rare diseases) on mouse models created by us or already…

Czech-Swiss project “SARS-Cov-2: understanding the entry, multi-organ spread and immune response in the context of vaccination and re-infection” received funding.

28. 01. 2022 Information News

Our collaboration with Luca Varani’s lab from the Institute for Research in Biomedicine in Bellinzona in Switzerland will expand thanks to the grants of the Czech and the Swiss Science Foundations. Both foundations decided to fund our joint project “SARS-Cov-2: understanding the entry, multi-organ spread and immune response in the context of vaccination and re-infection”…

Scientific Advisory Board met virtually

24. 01. 2022 Information News

On Friday 21st January 2022, the Scientific Advisory Board met virtually and discussed with CCP management the achievements of 2021 and future directions of the Centre for the period 2022-2029. Besides the traditional reports about 2021 outcomes in research services, research and development of new methodologies, the presented highlights focused on: Cardiovascular comprehensive screening for…

New CCP e-Newsletter 2021

11. 01. 2022 Information News

The first issue of our brand new online newsletter is available on We are delighted to share our recent achievements and updates on mouse phenogenomics, so from now on, the latest developments at CCP will be directly delivered to you via e-mail, with a dedicated website and interesting links for further reading. Enjoy reading…

CCP evaluated in the International peer-review of large research infrastructures in the Czech Republic in 2021

13. 12. 2021 Information News

In the first half of 2021, the Ministry of Education, Youth and Sports organized an international peer-review of large research infrastructures in the Czech Republic, which results were published in December. The purpose of this evaluation was to obtain independent expert reviews about the performance of large research infrastructures. CCP confirmed its top level. According…

Infrafrontier in the new ESFRI 2021 Roadmap

10. 12. 2021 Information News

The updated ESFRI Roadmap was published this week. INFRAFRONTIER is mentioned as an example of ESFRI Research Infrastructures in response to emergencies, specifically to the covid-19 crisis. “INFRAFRONTIER rapidly evolved a broad portfolio of services to evaluate the potential of new anti-COVID-19 compounds and therapeutics on suitable humanized models as well as BSL3 laboratories for…

1 2 3 8